The latest announcement is out from Vicarious Surgical (RBOT).
Vicarious Surgical Inc. stockholders, during their 2024 Annual Meeting, authorized a reverse stock split of its Class A and B common stock, with a decided ratio of 1-for-30, effective June 12, 2024. This consolidation reduced the number of outstanding shares significantly while maintaining the total authorized shares and the stock’s par value and voting rights. The stock began trading post-split on the NYSE under its existing symbol, “RBOT.” Additionally, existing warrants were adjusted to reflect the new share structure, with a modified exercise price post-split. The company also amended its 2021 Equity Incentive Plan, increasing the number of shares available for issuance and adjusting the numbers in accordance with the reverse stock split.
For a thorough assessment of RBOT stock, go to TipRanks’ Stock Analysis page.
